NCT05050916View on ClinicalTrials.gov

The Investigation of Vitamin D and Menstrual Cycles Trial, the inVitD Trial: A Phase II Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 17, 2023

Primary Completion Date

June 7, 2024

Study Completion Date

June 27, 2024

Conditions
Reproductive Issues
Interventions
DIETARY_SUPPLEMENT

Vitamin D

The High Dose Vitamin D arm will receive 50,000 IU/week of cholecalciferol. The Low Dose Vitamin D arm will receive 4,200 IU/week of cholecalciferol

OTHER

Placebo

Cellulose capsule

Trial Locations (2)

27709

NIEHS Clinical Research Unit (CRU), Research Triangle Park

48187

Henry Ford Health System, Detroit

All Listed Sponsors
lead

National Institute of Environmental Health Sciences (NIEHS)

NIH